Bacillus Coagulans
Best for
Ease constipation and stay regular
Proven strong benefit for 4–12 weeks · 1 meta-analysis , n=9.3k
18 papers · 5 claims · 67 outcomes scored · 5 positive
Outcomes
What bacillus coagulans actually does, by outcome
Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.
Softer stools, less straining, and more complete bowel movements.
Less belly swelling, pressure, and gassiness after meals.
Less pain, bloating, and unpredictable bowel habits from IBS.
Less cramping, rumbling, and unease throughout your gut.
Fewer loose stools, shorter episodes, and less fluid loss.
| Outcome | Effect | Evidence | Dose | Weeks | Rank |
|---|---|---|---|---|---|
| Ease constipation and stay regular Proven strong benefit | | 5 meta-analyses n=9.3k Meta-analyzed | 2000000000–6000000000 other | 4–12 wk | #1/18 |
| Reduce bloating and trapped gas Large effect, needs confirmation | | 2 RCTs n=166 | 2000000000 other | 4–12 wk | #4/12 |
| Ease irritable bowel symptoms Likely benefit | | 6 meta-analyses n=4.2k Meta-analyzed | 2000000000–6000000000 other | 6–13 wk | #2/11 |
| Improve overall digestive comfort Promising early signal | | 1 RCT n=40 | 2000000000 other | 13 wk | #5/9 |
| Reduce diarrhea and recover faster Likely modest benefit | | 1 RCT n=110 | 30 mg | 1 wk | #5/17 |
Sources
- 1. Probiotic Weizmannia coagulans MTCC 5856 as adjunct therapy in children's acute diarrhea-a randomized, double-blind, placebo-controlled study. (2023) ↑
- 2. Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study. (2018) ↑
- 3. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults. (2019) ↑
- 4. Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant]. (2021) ↑
- 5. Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. (2021) ↑
- 6. The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome-A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial. (2023) ↑
- 7. Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, placebo-controlled clinical trial. (2024) ↑
- 8. The effects of Bacillus coagulans MTCC 5856 on functional gas and bloating in adults: A randomized, double-blind, placebo-controlled study. (2023) ↑
- 9. Bacillus coagulans TCI711 Supplementation Improved Nonalcoholic Fatty Liver by Modulating Gut Microbiota: A Randomized, Placebo-Controlled, Clinical Trial. (2024) ↑
- 10. Efficacy of fermented grain using Bacillus coagulans in reducing visceral fat among people with obesity: a randomized controlled trial. (2023) ↑
Generated August 14, 2026
Related
More evidence for Bacillus Coagulans
Ingredient evidence
Ingredient evidence
NewLactobacillus rhamnosus
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewLactococcus acidophilus
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewSaccharomyces boullardii
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewZinc
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewAloe vera
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewBlack Seed
All scored outcomes
Aug 14, 2026